28 studies found for:    Open Studies | "Adrenal Insufficiency"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Adrenal Insufficiency in Critical Emergencies in Digestive Diseases
Conditions: Digestive Diseases;   Adrenal Insufficiency;   Gastrointestinal Bleeding;   Variceal Bleeding;   Acute Pancreatitis
Intervention:
2 Unknown  The Significance of Defensin Alpha 4 in the Pathophysiology of the Adrenal Insufficiency in Inflammatory Lung Diseases
Conditions: Adrenal Insufficiency;   Inflammatory Lung Diseases
Intervention:
3 Recruiting A European Post-Authorisation Observational Study (Registry) of Patients With Chronic Adrenal Insufficiency
Condition: Chronic Adrenal Insufficiency
Intervention:
4 Recruiting Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome
Conditions: Prader Willi Syndrome;   Adrenal Insufficiency
Interventions: Other: Low dose (1 mcg) ACTH stimulation test;   Other: Overnight metyrapone test
5 Recruiting Dual RElease Hydrocortisone Versus conventionAl Glucocorticoid replaceMent Therapy in Hypocortisolism (DREAM)
Conditions: Primary Adrenal Insufficiency;   Secondary Adrenal Insufficiency
Interventions: Drug: Plenadren;   Drug: Conventional glucocorticoid therapy
6 Recruiting Comparison of Cortisol Pump With Standard Treatment for Congenital Adrenal Hyperplasia
Conditions: Adrenal Insufficiency;   Excess Androgen;   Congenital Adrenal Hyperplasia (CAH)
Interventions: Drug: Hydrocortisone (Solucortef);   Device: Insulin pump (Medtronic)
7 Unknown  Adrenal Insufficiency in Cirrhotics With Ascites. Effects of Hydrocortisone on Renal and Haemodynamic Function
Condition: Cirrhosis With Ascites
Interventions: Drug: hydrocortisone;   Drug: dextrose solution 5%
8 Recruiting Difference in GC-induced Adrenal Insufficiency in RA Related to Polymorphisms in the Glucocorticoid Receptor Gene
Condition: Rheumatoid Arthritis
Intervention: Other: No intervention
9 Recruiting The Effect of Dexamethasone on Cortisol Levels in Patients Undergoing Thyroid Surgery
Condition: Adrenal Insufficiency
Interventions: Drug: Dexamethasone;   Other: Placebo
10 Recruiting Value of 25 mcg Cortrosyn Stimulation Test
Condition: Adrenal Insufficiency
Interventions: Procedure: ACTH stimulation test;   Procedure: 250 ug ACTH stimulation test;   Procedure: 25 ug Cortrosyn stimulation test;   Procedure: Insulin tolerance test;   Procedure: 1 ug cortrosyn test
11 Recruiting Evaluation of Patients With Endocrine-Related Conditions
Conditions: Adrenal Insufficiency;   Pituitary Neoplasm;   Obesity
Intervention:
12 Recruiting Continuous Subcutaneous Hydrocortisone Infusion In Addison`s Disease and Type 1 Diabetes
Conditions: Addison Disease;   Type 1 Diabetes
Interventions: Other: Cortef;   Other: Solu-cortef
13 Unknown  Exercise Capacity and Recovery in Addison's Disease
Condition: Addison's Disease
Intervention: Other: ergometry
14 Recruiting Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal Hyperplasia
Conditions: Addison Disease;   Adrenal Hyperplasia Congenital
Interventions: Drug: Solu-Cortef;   Drug: Cortef
15 Recruiting Biomarker(s) for Glucocorticoids
Condition: Addison Disease
Interventions: Drug: Hydrocortisone;   Drug: Placebo
16 Available Expanded Access for Lorenzo's Oil (GTO/GTE) in Adrenoleukodystrophy
Condition: X-linked Adrenoleukodystrophy
Intervention: Drug: Lorenzo's Oil
17 Recruiting HSCT for High Risk Inherited Inborn Errors
Conditions: Adrenoleukodystrophy;   Metachromatic Leukodystrophy;   Globoid Cell Leukodystrophy;   Tay Sachs Disease;   Sandhoffs Disease;   Wolman Disease;   I-Cell Disease;   Sanfilippo Syndrome;   GM1 Gangliosidosis
Interventions: Drug: Clofarabine;   Procedure: Total body Irradiation;   Drug: Melphalan;   Biological: Hematopoietic Stem Cell Transplantation;   Drug: Alemtuzumab;   Drug: mycophenylate mofetil;   Device: Cyclosporine A;   Drug: Hydroxyurea
18 Recruiting MT2013-31:Allo BMT for Metabolic Disorders, Osteopetrosis and Males With Rett Syndrome
Conditions: Mucopolysaccharidosis I;   Mucopolysaccharidosis II;   Mucopolysaccharidosis VI;   Mucopolysaccharidosis VII;   Hurler Syndrome;   Hunter Syndrome;   Maroteaux Lamy Syndrome;   Sly Syndrome;   Glycoprotein Metabolic Disorders;   Alpha Mannosidosis;   Fucosidosis;   Aspartylglucosaminuria;   Adrenoleukodystrophy;   Peroxisomal Disorders;   Osteopetrosis;   Rett Syndrome;   Sphingolipidosis;   Gangliosidosis;   Globoid Cell Leukodystrophy;   Metachromatic Leukodystrophy;   Niemann Pick B;   Niemann Pick C Subtype 2;   I-cell Disease
Interventions: Procedure: blood stem cell transplant;   Drug: Rabbit Anti-Thymocyte Globulin (ATG);   Drug: Fludarabine;   Drug: Busulfan;   Drug: Cyclophosphamide;   Drug: Cyclosporine A (CSA);   Drug: Methylprednisolone;   Drug: Mycophenolate Mofetil (MMF);   Drug: Granulocyte-Colony Stimulating Factor (G-CSF);   Drug: Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF);   Drug: N-acetylcysteine;   Drug: Celecoxib;   Drug: Vitamin E;   Drug: Alpha Lipoic Acid
19 Recruiting A Prospective and Partially Retrospective Study to Characterize Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Childhood Cerebral Adrenoleukodystrophy
Condition: X-linked Adrenoleukodystrophy Cerebral Childhood
Intervention: Genetic: Allogeneic Hematopoietic Stem Cell Transplantation
20 Recruiting A Phase 2/3 Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Childhood Cerebral Adrenoleukodystrophy (CCALD)
Conditions: Childhood Cerebral Adrenoleukodystrophy;   (X-linked Adrenoleukodystrophy Cerebral Childhood)
Interventions: Genetic: Lenti-D Drug Product;   Drug: Busulfan;   Drug: Cyclophosphamide;   Drug: Filgrastim

   Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results    Last Page
Indicates status has not been verified in more than two years